BYLVAY 600 micrograms, hard capsule 30 capsules
Active ingredients: ODÉVIXIBAT, ODÉVIXIBAT SESQUIHYDRATÉ
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BYLVAY 600 microgrammes, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 gélule(s)
- Marketing authorisation holder
- IPSEN PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
68818769CIP73023707CIP133400930237076Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ODÉVIXIBAT SESQUIHYDRATÉgélule | — | SA |
| ODÉVIXIBATgélule | 600 microgrammes · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.